Wearables to Define Postpartum Blood Pressure Trajectories and Facilitate Evidence-based Monitoring Guidelines
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Aug 26, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Postpartum birthing person 18 years of age or older
- • At least 20 weeks gestation at time of delivery
- • Meeting criteria for 1 of 3 risk categories for PP HTN and hypertensive morbidity
- • Planned postpartum care at UCSD
- Exclusion Criteria:
- • Inability to give informed consent
- • Institutionalization for psychiatric disorder, mental deficiency or incarcerated
- • Initiation of antihypertensive therapy prior to discharge from delivery hospitalization.
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported